ConductScience.org, home

Paper2209342

Biguanides and sulfonylureas as combination therapy in NIDDM.

Hermann LS. Diabetes Care, 1990. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Biguanides and sulfonylureas as combination therapy in NIDDM. Papers, record 2209342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2209342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biguanides and sulfonylureas as combination therapy in NIDDM.
PubMed
Journal
Diabetes Care
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.85
iCite
Revised in PubMed
2019-05-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hermann LSL S

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiguanidesMajor topic
Diabetes Mellitus, Type 2Major topic
Lipid MetabolismMajor topic
Sulfonylurea CompoundsMajor topic
Adult
Aged
Drug Therapy, Combination
Humans
Middle Aged

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
37581618Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.Diabetologia2023https://conductscience.org/library/papers/37581618PubMed
36619226A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.Int J Med Sci2023https://conductscience.org/library/papers/36619226PubMed
36617249Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients.J Clin Endocrinol Metab2023https://conductscience.org/library/papers/36617249PubMed
36085061Hypertension attenuates the link of osteoprotegerin to reduced baroreflex sensitivity in type 2 diabetes mellitus patients on oral antidiabetic and antihypertensive therapy - a cross sectional study.BMC Endocr Disord2022https://conductscience.org/library/papers/36085061PubMed
32269463A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.Ethn Dis2020https://conductscience.org/library/papers/32269463PubMed
27002150Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production.J Biol Chem2016https://conductscience.org/library/papers/27002150PubMed
25060887Metformin pharmacogenomics: current status and future directions.Diabetes2014https://conductscience.org/library/papers/25060887PubMed
11560289Modern pharmacotherapies for type 2 diabetes mellitus.J Natl Med Assoc2001https://conductscience.org/library/papers/11560289PubMed
10392666A risk-benefit assessment of metformin in type 2 diabetes mellitus.Drug Saf1999https://conductscience.org/library/papers/10392666PubMed
9972673Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?J Endocrinol Invest1998https://conductscience.org/library/papers/9972673PubMed
9506242Oral antidiabetic agents. A guide to selection.Drugs1998https://conductscience.org/library/papers/9506242PubMed
9279500Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments.Drugs1997https://conductscience.org/library/papers/9279500PubMed
8972242Oral antidiabetic drug use in the elderly.Drugs Aging1996https://conductscience.org/library/papers/8972242PubMed
8435549Treating non-insulin-dependent diabetes. Oral agents or insulin?Can Fam Physician1993https://conductscience.org/library/papers/8435549PubMed
8075474Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.Drugs Aging1994https://conductscience.org/library/papers/8075474PubMed
7848543Comparative tolerability profiles of oral antidiabetic agents.Drug Saf1994https://conductscience.org/library/papers/7848543PubMed
7601013Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.Drugs1995https://conductscience.org/library/papers/7601013PubMed
1742694Non-insulin-dependent (type II) diabetes mellitus.CMAJ1991https://conductscience.org/library/papers/1742694PubMed
1521215Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.CMAJ1992https://conductscience.org/library/papers/1521215PubMed
1280575Management of non-insulin-dependent diabetes mellitus.Drugs1992https://conductscience.org/library/papers/1280575PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2209342

GET https://conductscience.org/api/papers/v1/2209342/authors